Anta Sports Expands Global Footprint With Strategic Puma Stake 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Global Bioenergies to Participate at 30th Annual ROTH Capital Conference
LOS ANGELES, CA and PARIS, France - March 5, 2018 - Global Bioenergies (Euronext Growth: ALGBE) a leader in industrial biotechnology developing a process to convert renewable resources into hydrocarbons through fermentation, will be participating at the 30th Annual ROTH Capital Conference. The conference is being held on March 11-14, 2018 at The Ritz-Carlton in Dana Point, CA.
Marc Delcourt, Chief Executive Officer will be conducting one-on-one meetings with investors and analysts at the conference on Monday and Tuesday, March 12-13.
Investors interested in arranging one-on-one meetings should contact your ROTH representative. Conversely, you may also call or email Lytham Partners at (602) 889-9700 or [email protected].
A copy of the slide presentation Global Bioenergies will be referencing during the conference will be available in the Investor Relations section of the company's website at www.globalbioenergies-invest.com.
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performance of its process, to operate its demo plant in Germany, and to prepare the first full-scale plant through a joint venture with Cristal Union, named IBN-One. Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 - ALGBE).
Stay informed! Subscribe to our newsfeed on
www.global-bioenergies.com
Follow us on Twitter: @GlobalBioenergi
Contact
GLOBAL BIOENERGIES
Jean-Baptiste Barbaroux
Chief Corporate Officer
Phone: +33 1 64 98 20 50
[email protected]
Attachment:
http://www.globenewswire.com/NewsRoom/AttachmentNg/2a4ce80f-495c-4360-a923-ca1e96ad5ee6
